Minjie Li
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 3
- Health top 2%
- Obstetrics and Gynecology top 5%
- Modeling and Simulation top 5%
- Environmental Chemistry top 10%
- Per- and polyfluoroalkyl substances research 12
-
- Effects and risks of endocrine disrupting chemicals 11
- Toxic Organic Pollutants Impact 10
- Air Quality and Health Impacts 4
-
- Sarcoma Diagnosis and Treatment 4
-
- Estrogen and related hormone effects 4
- Journals
- The Science of The Total Environment (4 papers)Cancer (1 paper)Journal of Hazardous Materials (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Minjie Li
42 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Infectious Diseases 707
- Health 303
- Obstetrics and Gynecology 149
- Modeling and Simulation 75
- Environmental Chemistry 99
Countries citing papers authored by Minjie Li
This map shows the geographic impact of Minjie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjie Li more than expected).
Fields of papers citing papers by Minjie Li
This network shows the impact of papers produced by Minjie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjie Li. The network helps show where Minjie Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Minjie Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 15 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 0 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 7 | |
| 17 | Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trialsbreakdown → | 2021 | 173 |
| 18 | Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trialbreakdown → | 2021 | 211 |
| 19 | 2020 | 24 | |
| 20 | 2018 | 9 |
About Minjie Li
Minjie Li is a scholar working on Health, Toxicology and Mutagenesis, Environmental Chemistry and Obstetrics and Gynecology, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Per- and polyfluoroalkyl substances research (12 papers), Effects and risks of endocrine disrupting chemicals (11 papers), Toxic Organic Pollutants Impact (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Air Quality and Health Impacts (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Estrogen and related hormone effects (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (707 citations), Health (303 citations) and Obstetrics and Gynecology (149 citations). Minjie Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhiwei Wu, Lei Wang, Yuliang Zhao, Wanqi Yang, Zhiwei Jiang, Weidong Yin, Bihua Han, Guoqing Zhao, Panpan Chen and Yuzhu Ding. Their work appears in journals such as The Science of The Total Environment, Cancer and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.